[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-364327-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-364327-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","hereditary-colorectal-cancer-syndromes-and-inflammatory-bowel-disease-results-from-a-registry-based-study","Hereditary colorectal cancer syndromes and inflammatory bowel disease - results from a registry-based study","","Study investigates progression of high-grade dysplasia and colorectal cancer in patients carrying hereditary colorectal cancer syndromes alongside inflammatory bowel diseases. Natural history was traced for individuals referred to the Hereditary Digestive Tumors Registry in Milan with confirmed hereditary colorectal cancer syndromes and concomitant IBDs. From 1989–2024, 6 IBD patients with 450 APC-associated polyposis and 1050 Lynch syndrome cases were identified; CRC developed early in advanced stages and was linked to surgical outcomes, highlighting the need for strict surveillance and early management.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/hereditary-colorectal-cancer-syndromes-and-inflammatory-bowel-disease-results-from-a-registry-based-study/364327/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/hereditary-colorectal-cancer-syndromes-and-inflammatory-bowel-disease-results-from-a-registry-based-study/364327.png","ImageObject",300,407,{"name":42,"@type":43},"Lucas Martin","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study’s purpose regarding high-grade dysplasia and colorectal cancer?","Question",{"text":63,"@type":64},"The study examined how high-grade dysplasia/colorectal cancer progresses in patients with hereditary colorectal cancer syndromes who also have inflammatory bowel diseases.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were patients identified and which registry was used?",{"text":68,"@type":64},"Patients were described from a series referred to the Hereditary Digestive Tumors Registry at the Fondazione IRCCS Istituto Nazionale dei Tumori in Milan with confirmed hereditary colorectal cancer syndromes and concomitant IBDs.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the results show about timing and stage of colorectal cancer onset?",{"text":72,"@type":64},"CRC occurred early in advance stage among patients with coexistent hereditary colorectal cancer syndromes and IBDs; in some cases CRC was diagnosed shortly after IBD diagnosis or simultaneously.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},364327,1790230688,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":111,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":33,"preview_urls":144},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","International Journal of Colorectal Disease (2025) 40:24  \n[https://doi.org/10.1007/s00384-025-04808-x](https://doi.org/10.1007/s00384-025-04808-x)  \nHereditary colorectal cancer syndromes and inflammatory bowel disease: results from a registry‑based study  \nLauricella S. 1,5 · Ricci M. T.1 · Tontini G. E.2,3 · Cavallaro F.2 · Rausa E. 1,5 · Signoroni S.1 · Brignola C.1 · Pasanisi P.4 · Vitellaro M. 1,5  \nAccepted: 7 January 2025 © The Author(s) 2025  \nAbstract  \nPurpose In this study, we investigated the progression of high-grade dysplasia (HGD)/CRC in patients with hereditary colorectal cancer syndromes (HCSS) and concomitant inflammatory bowel diseases (IBDs) .  \nMethods We described the natural history of a series of patients with confirmed diagnosis of hereditary colorectal cancer syndromes (HCCSs) and concomitant IBDs who were referred to the Hereditary Digestive Tumors Registry at the Fondazione IRCCS Istituto Nazionale dei Tumori of Milan.  \nResults Between January 1989 and April 2024, among 450 patients with APC-associated polyposis and 1050 patients with Lynch syndrome (LS), we identified six patients with IBDs (five with UC, one with ileal penetrating CD) and concomitant HCCSs (five with LS, one with APC-associated polyposis). Three patients developed CRC (two patients with stage IIA, and one with stage IIIA); in one patient, CRC occurred over a median follow-up of 12 months after IBD diagnosis, while in two, both conditions were diagnosed simultaneously. The median age at initial diagnosis of CRC was 33 years (range 27–41) . Five patients (83.3%) underwent surgical procedures (three colonic resections for carcinoma and two for other reasons) . Most of them progressed to precancerous or cancerous colonic lesions at a young age. Notably, all patients with CRC hada diagnosis of UC.  \nConclusion IBD patients with coexistent HCCSs can develop early CRC onset at an advanced stage. These patients should be always referred to tertiary referral centers for strict surveillance programs and early surgical management of advanced colorectal neoplastic lesions. Noninvasive biomarkers of neoplastic changes are advocated to further improve the management of IBD patients with HCCSs.  \nKeywords Lynch syndrome · FAP · Ulcerative colitis · Crohn’s disease · APC-associated polyposis · Colorectal cancer  \n* Lauricella S.  \nsara.lauricella@istitutotumori.mi.it;  \n[lauricella3008@gmail.com](lauricella3008@gmail.com)  \n1 Hereditary Digestive Tract Tumors Unit, Fondazione IRCCSIstituto Nazionale Dei Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy  \n2 Gastroenterology and Endoscopy Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy  \n3 Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy  \n4 Nutrition Research and Metabolomics Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy  \n5 Colorectal Surgery Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy  \nAbbreviations  \nCRC Colorectal cancer  \nIBD Inflammatory bowel diseases  \nUC Ulcerative colitis  \nCD Crohn’s disease  \nHCCS Hereditary colorectal cancer syndromes QoL Quality of life  \nPSC Primary sclerosing cholangitis MMR Mismatch repair  \nHGD High-grade dysplasia  \nAJCC American Joint Committee on Cancer BMI Body mass index  \nEoCRC Early-onset colorectal cancer  \nIntroduction  \nColorectal cancer (CRC) is the most commonly diagnosed malignancy and the second leading cause of cancer-related death globally [1]. The incidence of CRC varies geographically and ethnically and is influenced by age, with a notable increase in incidence among individuals younger than 50 years in recent decades [2] .  \nInflammatory bowel diseases (IBDs), including both ulcerative colitis (UC) and Crohn’s disease (CD), as well as hereditary colorectal cancer syndromes (HCCSs), contribute significantly to CRC risk [3–5] .  \nIBDs are chronic remitting, and relapsing inflammatory conditions of the gastrointestinal tract, which hav","cbCaidzYfZ74nMEb","https://ap.wps.com/l/cbCaidzYfZ74nMEb","pdf",972561,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Colorectal cancer burden\n## Role of inflammatory bowel diseases\n## Pathogenesis and surveillance recommendations\n## Hereditary colorectal cancer syndromes and Lynch syndrome","[{\"question\":\"What was the study’s purpose regarding high-grade dysplasia and colorectal cancer?\",\"answer\":\"The study examined how high-grade dysplasia/colorectal cancer progresses in patients with hereditary colorectal cancer syndromes who also have inflammatory bowel diseases.\"},{\"question\":\"How were patients identified and which registry was used?\",\"answer\":\"Patients were described from a series referred to the Hereditary Digestive Tumors Registry at the Fondazione IRCCS Istituto Nazionale dei Tumori in Milan with confirmed hereditary colorectal cancer syndromes and concomitant IBDs.\"},{\"question\":\"What did the results show about timing and stage of colorectal cancer onset?\",\"answer\":\"CRC occurred early in advance stage among patients with coexistent hereditary colorectal cancer syndromes and IBDs; in some cases CRC was diagnosed shortly after IBD diagnosis or simultaneously.\"}]","Hereditary colorectal cancer syndromes and inflammatory bowel disease - results from a registry-based study | PDF",1790157020,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/09b3ebb0f84b5fdb038607937685db1c.webp",983,1305,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/13fdd607e30e2d67743f14c9c2c7689e.webp",982,1304,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33f55f583e978a2f8dd4b36e187d94c5.webp",981,1303,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/419450dadc40a6188de1e60d0d5dcffc.webp",980,1301]